Orthofix Medical Inc. - Common Stock (OFIX)
19.04
+0.28 (1.49%)
Orthofix International NV specializes in the development and commercialization of innovative orthopedic and spinal devices
The company focuses on providing solutions that enhance the quality of life for patients through advanced medical technologies and products. Orthofix offers a diverse range of offerings, including orthopedic implants, spinal fusion devices, and biologics, catered to healthcare professionals in various settings. By emphasizing research and development, the company aims to address unmet clinical needs and improve patient outcomes in the rapidly evolving field of orthopedic and spinal care.
![](https://cdn.benzinga.com/files/images/story/2025/01/30/Meta-Platforms-Inc-.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · January 30, 2025
![](https://cdn.benzinga.com/files/images/story/2025/01/22/A-Closeup-Of-Doctor-With-Stethoscope-Ope.jpeg?width=1200&height=800&fit=crop)
Canaccord Genuity initiates coverage on Orthofix Medical with a Buy rating and $24 price target, citing growth potential and strong financial outlook.
Via Benzinga · January 22, 2025
![](https://cdn.benzinga.com/files/images/story/2025/01/22/Analysts.png?width=1200&height=800&fit=crop)
Via Benzinga · January 22, 2025
![](https://cdn.benzinga.com/files/images/story/2025/01/17/Intel--Cleanspark--Super-Micro-Computer-.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · January 17, 2025
![](https://g.foolcdn.com/editorial/images/747447/person-experiencing-back-pain-1.jpg)
The company had a big leadership change after an investigation.
Via The Motley Fool · September 12, 2023
![](https://cdn.benzinga.com/files/images/story/2024/11/08/lowes-shutter.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · November 8, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
OFIX stock results show that Orthofix Medical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 6, 2024
![](https://cdn.benzinga.com/files/images/story/2024/05/08/Datadog.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · May 8, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
OFIX stock results show that Orthofix Medical met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 7, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
OFIX stock results show that Orthofix Medical missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 5, 2024
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • NIO (NYSENIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.
Via Benzinga · March 5, 2024
![](https://cdn.benzinga.com/files/images/story/2024/01/09/acuity_brands_-_logo.jpg?width=1200&height=800&fit=crop)
U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday.
Via Benzinga · January 9, 2024
![](https://cdn.benzinga.com/files/images/story/2023/12/04/alaska_air_group_-_logo.jpg?width=1200&height=800&fit=crop)
U.S. stock futures traded lower this morning, with the Dow Jones futures falling more than 50 points on Monday.
Via Benzinga · December 4, 2023
![](https://www.investors.com/wp-content/uploads/2019/07/UBERSTOCKTOBUY-Evergreen-070819-Shutter.jpg)
The ride-hailing giant will join the index as part of a quarterly rebalancing.
Via Investor's Business Daily · December 1, 2023
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Via Benzinga · October 20, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · September 12, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · September 12, 2023
![](https://cdn.benzinga.com/files/images/story/2023/09/12/image21.jpeg?width=1200&height=800&fit=crop)
Gainers Tenon Medical, Inc. (NASDAQTNON) shares climbed 63.5% to $0.2351 after the company announced it has withdrawn its proposed public offering of shares of its common stock.
Via Benzinga · September 12, 2023
![](https://cdn.benzinga.com/files/images/story/2023/08/09/akamai_technologies_-_logo.jpg?width=1200&height=800&fit=crop)
U.S. stocks traded lower, with the Nasdaq Composite falling around 100 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via Benzinga · August 9, 2023
![](https://cdn.benzinga.com/files/images/story/2023/08/09/cutera_-_logo.jpg?width=1200&height=800&fit=crop)
Gainers Tango Therapeutics, Inc. (NASDAQTNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss.
Via Benzinga · August 9, 2023